MSFT Stock Today: March 18 — Pharma Blockchain Spend Set to Surge
Blockchain in pharmaceutical 供 is moving from pilots to scale. A new update projects $6.57B by 2033 at a 21.5% CAGR, with Microsoft among key vendors. For German investors, stricter EU traceability rules and anti counterfeit drugs controls point to steady cloud workloads. We explain how this trend can support Azure demand, what the latest MSFT snapshot shows, and what to watch into the next earnings date. Blockchain in pharmaceutical 供 could be a durable theme across Europe.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →